Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MRNA-1012.1 by Moderna for Seasonal Influenza: Likelihood of Approval
MRNA-1012.1 is under clinical development by Moderna and currently in Phase II for Seasonal Influenza. According to GlobalData, Phase II...